Neuroptika
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(857) 600-1424Website
www.neuroptika.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Neuroptika
Neuroptika is a clinical stage biotechnology company focused on developing novel regenerative treatments for ophthalmic diseases, particularly targeting retinal health. Their innovative therapies aim to protect and regenerate corneal nerves, addressing conditions such as glaucoma and age-related macular degeneration. The company is dedicated to improving patient outcomes through cutting-edge research and has a strong pipeline of products in various stages of clinical trials. Neuroptika's intended clients include patients suffering from vision loss and eye diseases, as well as healthcare professionals seeking advanced treatment options.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuroptika your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Neuroptika has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Neuroptika has new funding data
Product Launch: Get notified when Neuroptika launches new products
Check out if Neuroptika is spiking on competitors!
Neuroptika, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Neuroptika had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Neuroptika
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Neuroptika recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Neuroptika as Masked Content
Find 3 more new buyers
Compare Similar Companies to Neuroptika
Compare insights from companies similar to Neuroptika, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neuroptika
<$5M
1-10
Private
-
2019
N/A
Company Profile Activity
Activity Insights
Neuroptika is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neuroptika is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuroptika.
Neuroptika Tech Stack
A closer look at the technologies used by Neuroptika
Neuroptika News & Media
Neuroptika Announces Enrollment Of First Patient In Phase 2 Clinical Trial For Dry Eye Disease
Neuroptika, a privately held biotechnology company focused on the development of novel regenerative treatments for ophthalmic diseases, today announced that the first patient was enrolled in a Phase 2 clinical trial of NRO-1 for the treatment of dry eye disease. NRO-1 is a novel therapeutic with the potential to protect and regenerate corneal nerves in ophthalmic diseases.Neuroptika Announces Enrollment Of First Patient In Phase 2 Clinical Trial For Dry Eye Disease
CAMBRIDGE, Mass., Jan. 16, 2020 /PRNewswire/ -- Neuroptika, a privately held biotechnology company focused on the development of novel regenerative treatments for ophthalmic diseases, today announced that the first patient was enrolled in a Phase 2 clinical trial of NRO-1 for the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuroptika
Sign Up For FreeTo access detailed company insights
Neuroptika is a clinical stage biotechnology company focused on developing novel regenerative treatments for ophthalmic diseases, particularly targeting retinal health. Their innovative therapies aim to protect and regenerate corneal nerves, addressing conditions such as glaucoma and age-related macular degeneration. The company is dedicated to imp... Read More
